000 01515 a2200397 4500
005 20250515184242.0
264 0 _c20101214
008 201012s 0 0 eng d
022 _a1440-1681
024 7 _a10.1111/j.1440-1681.2009.05281.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHe, Jian-Gui
245 0 0 _aB-type natriuretic peptide attenuates cardiac hypertrophy via the transforming growth factor-ß1/smad7 pathway in vivo and in vitro.
_h[electronic resource]
260 _bClinical and experimental pharmacology & physiology
_cMar 2010
300 _a283-9 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aCardiomegaly
_xmetabolism
650 0 4 _aCells, Cultured
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aMale
650 0 4 _aNatriuretic Peptide, Brain
_xadministration & dosage
650 0 4 _aRats
650 0 4 _aRats, Sprague-Dawley
650 0 4 _aSignal Transduction
_xdrug effects
650 0 4 _aSmad7 Protein
_xphysiology
650 0 4 _aTransforming Growth Factor beta1
_xphysiology
700 1 _aChen, Yi-Li
700 1 _aChen, Bai-Li
700 1 _aHuang, Yi-Yi
700 1 _aYao, Feng-Juan
700 1 _aChen, Sheng-Long
700 1 _aDong, Yu-Gang
773 0 _tClinical and experimental pharmacology & physiology
_gvol. 37
_gno. 3
_gp. 283-9
856 4 0 _uhttps://doi.org/10.1111/j.1440-1681.2009.05281.x
_zAvailable from publisher's website
999 _c19120821
_d19120821